3602 Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 

breastfeeding necessitate the need for 

extra precautions when these drugs are 

handled by both males and females who 

are trying to conceive, women who may 

become or who are pregnant, and 

women who are breast feeding. 

Recommendations for temporary 

reassignment of duties or alternative 

duty are included in this guidance 

document. 

Information Needs: Additional data 

and information are needed to assist 

NIOSH to protect the reproductive 

health of healthcare workers who come 

in contact with antineoplastic drugs. 

Information is needed for: (1) 

Appropriateness of guidance, (2) Effect 

on work practices, (3) Confidentiality 

issues, (4) Financial impact. 

NIOSH seeks to obtain materials, 

including published and unpublished 

reports and research findings, to 

evaluate: 

• Relevant publications not included 

in this document 

• Institutional and organizational 

policies in effect 

• Other relevant information related 

to this topic 

References 

Connor TH, DeBord G, Pretty JR, Oliver 

MS, Roth TS, Lees PSJ, Krieg EF, 

Rogers B, Escalante CP, Toennis CA, 

Clark JC, Johnson B, McDiarmid MA 

[2010]. Evaluation of antineoplastic 

drug exposure of health care workers 

at three university-based US cancer 

centers. J Occup Environ Med 

52:1019–1027. 

Connor TH, Lawson CC, Polovich M, 

McDiarmid MA [2014]. Reproductive 

health risks associated with 

occupational exposures to 

antineoplastic drugs in health care 

settings. JOEM 56: 901–10. 

Lawson CC, Rocheleau CM, Whelan EA, 

Lividoti Hibert EN, Grajewski B, 

Spiegelman D, Rich-Edwards JW 

[2012]. Occupational exposures 

among nurses and risk of spontaneous 

abortions. Am J Obstet Gynecol 

206(327):e1–8. 

FOR FURTHER INFORMATION CONTACT: 

Thomas H. Connor, NIOSH, Division of 

Applied Research and Technologies, 

Robert A. Taft Laboratories, 1090 

Tusculum Avenue, MS–C23, Cincinnati, 

Ohio 45226, Phone: (513) 533–8399, 

Email: hazardousdrugs@cdc.gov. 

Dated: January 15, 2015. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–01209 Filed 1–22–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[CDC–2015–0002, Docket Number NIOSH– 

244–A] 

Request for Comment on the Second 

Decade of National Occupational 

Research Agenda (NORA) 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Request for information and 

comment. 

SUMMARY: The National Institute for 

Occupational Safety and Health of the 

Centers for Disease Control and 

Prevention announces the availability of 

NIOSH Docket Number 244–A entitled 

Request for Comment on the Second 

Decade of NORA for public comment. 

To view the notice, visit http://

www.regulations.gov and enter CDC– 

2015–0002 in the search field and click 

‘‘Search.’’ 

Public comment period: Electronic or 

written comments must be received by 

March 24, 2015. 

ADDRESSES: You may submit comments, 

identified by CDC–2015–0002 and 

Docket Number NIOSH–244–A, by 

either of the following two methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov Follow the 

instructions for submitting comments. 

• Mail: National Institute for 

Occupational Safety and Health, NIOSH 

Docket Office, 1090 Tusculum Avenue, 

MS C–34, Cincinnati, Ohio 45226–1998. 

Instructions: All information received 

in response to this notice must include 

the agency name and docket number 

[CDC–2015–0002; NIOSH–244–A]. All 

relevant comments received will be 

posted without change to http://

www.regulations.gov, including any 

personal information provided. All 

electronic comments should be 

formatted in Microsoft Word. All 

information received in response to this 

notice will also be available for public 

examination and copying at the NIOSH 

Docket Office, 1150 Tusculum Avenue, 

Room 155, Cincinnati, OH 45226. 

SUPPLEMENTARY INFORMATION: 

Background: The National Institute 

for Occupational Safety and Health 

(NIOSH) is evaluating the impact of the 

National Occupational Research Agenda 

(NORA, http://www.cdc.gov/niosh/ 

nora/). NORA is a partnership program 

to stimulate innovative research and 

improved workplace practices. Begun in 

1996, NORA has become a research 

framework for NIOSH and the nation. 

Diverse parties collaborate to identify 

the most critical issues in workplace 

safety and health. Partners work 

together to develop goals and objectives 

for addressing these needs. Participation 

in NORA is broad, including 

stakeholders from universities, large and 

small businesses, professional societies, 

government agencies, and worker 

organizations. 

The program entered its second 

decade in 2006 with a new sector based 

structure to better move research to 

practice within workplaces. The 

national agenda is developed and 

implemented through the NORA Sector 

Councils. Each Council develops and 

maintains an agenda for its sector 

(http://www.cdc.gov/niosh/nora/). The 

collection of national sector agendas is 

the agenda for the nation for 

improvements in occupational safety 

and health through research and 

partnerships. Representing all 

stakeholders, the councils use an open 

process to set goals, develop strategies, 

encourage partnerships, and promote 

improved workplace practices. 

NIOSH is reviewing the 

accomplishments of the second decade 

of NORA and is preparing for the third 

decade, which will start in 2016. As a 

part of this review, NIOSH is seeking 

comments from partners and the public 

to evaluate the second decade and plan 

for the third decade of NORA. NIOSH is 

requesting the following feedback: 

Please describe the most significant 

successes and challenges of your engagement 

with NIOSH during the second decade of 

NORA (2006 to present). 

FOR FURTHER INFORMATION CONTACT: 

Sidney C. Soderholm, Ph.D., NORA 

Coordinator, CDC—National Institute 

for Occupational Safety and Health, 395 

E St. SW., Suite 9200, Washington, DC 

20201 or call (202) 245–0665. This is 

not a toll free number. 

Dated: January 15, 2015. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–01208 Filed 1–22–15; 8:45 am] 

BILLING CODE 4163–19–P 


tkelley on DSK3SPTVN1PROD with NOTICES